# ELUXADOLINE
> **ANDA213576** · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMACEUTICALS INC · Approved 2021-09-23
## Drug
- **FDA Application Number:** ANDA213576
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ELUXADOLINE
- **Generic name:** Eluxadoline
- **Active ingredients:** ELUXADOLINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN PHARMACEUTICALS INC
- **First approval:** 2021-09-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213576)
---
*AI Analytics · CC0 1.0*